Shingles News and Research

RSS

Shingles (herpes zoster) is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox — the varicella-zoster virus. The first sign of shingles is often burning or tingling pain, or sometimes numbness or itch, in one particular location on only one side of the body.

Varicella vaccine is almost 90 percent effective against chickenpox

The varicella vaccine is almost 90 percent effective against chickenpox, but its impact on herpes zoster (shingles) is unknown and needs wider surveillance, Yale School of Medicine researchers write in today's New England Journal of Medicine (NEJM) perspective section.

7 Feb 2005

Vaccine Treatment and Evaluation Units (VTEUs) supply the nurse power necessary to beat back or altogether prevent infectious disease

Flu. Smallpox. Anthrax. Whooping cough. The words represent a veritable murderers' row of infectious agents whose death toll runs in the millions.

23 Dec 2004

Guideline evaluates treatments for postherpetic neuralgia

A new guideline from the American Academy of Neurology evaluates treatments for postherpetic neuralgia. The guideline is published in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.

28 Sep 2004

Chickenpox (Varicella) vaccine has saved the U.S. hundreds of millions of dollars since its introduction

A new University of Michigan study has found that the Chickenpox (Varicella) vaccine has saved the U.S. hundreds of millions of dollars since its introduction in 1995 by preventing the kinds of severe cases that used to send children, teens and adults to the hospital.

7 Sep 2004

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

A beautiful, but often deadly, snail from the sea has been revealed as a largely untapped source of natural healing powers for a range of illnesses from chronic pain to diseases of the brain.

20 Aug 2004

Network formed to tackle potentially fatal reaction to smallpox vaccine

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), launched the Atopic Dermatitis and Vaccinia Network (ADVN), a nationwide research group that seeks to reduce the risk of eczema vaccinatum (EV), a severe and potentially deadly complication of smallpox immunization.

19 May 2004

Indicators identify shingles patients who have an increased risk of developing persistent pain

Researchers have recently confirmed a set of indicators that, alone and in combination, identify shingles patients who have an increased risk of developing persistent pain after the shingles rash heals. Results and implications of their study will be presented in the May 11 issue of Neurology, the scientific journal of the American Academy of Neurology.

10 May 2004

Shingles News and Research

Further Reading

Varicella vaccine is almost 90 percent effective against chickenpox

Vaccine Treatment and Evaluation Units (VTEUs) supply the nurse power necessary to beat back or altogether prevent infectious disease

Guideline evaluates treatments for postherpetic neuralgia

Chickenpox (Varicella) vaccine has saved the U.S. hundreds of millions of dollars since its introduction

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

Network formed to tackle potentially fatal reaction to smallpox vaccine

Indicators identify shingles patients who have an increased risk of developing persistent pain

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Uniting Against Resistance: The World Health Organization for World Antimicrobial Awareness Week 2023

Tackling Antimicrobial Resistance: A Conversation with Dr. Beverley Isherwood

Latest News